CD4+Foxp3+ regulatory T cells prolong drug-induced disease remission in (NZBxNZW) F1 lupus mice
Open Access
- 1 January 2013
- journal article
- Published by Springer Science and Business Media LLC in Arthritis Research & Therapy
- Vol. 15 (1), R35
- https://doi.org/10.1186/ar4188
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Annals of the New York Academy of Sciences, 2012
- Systemic Lupus ErythematosusNew England Journal of Medicine, 2011
- Pathogenesis of human systemic lupus erythematosus: recent advancesTrends in Molecular Medicine, 2010
- Key autoantigens in SLERheumatology, 2005
- Pathogenesis of systemic lupus erythematosusJournal of Clinical Pathology, 2003
- Systemic Lupus ErythematosusCell, 1996
- Long‐term preservation of renal function in patients with lupus nephritis receiving treatment that includes cyclophosphamide versus those treated with prednisone onlyArthritis & Rheumatism, 1991
- Therapy of Lupus NephritisNew England Journal of Medicine, 1986
- Does corticosteroid therapy affect the survival of patients with systemic lupus erythematosus?Arthritis & Rheumatism, 1979
- Cyclophosphamide in Lupus Nephritis: A Controlled TrialAnnals of Internal Medicine, 1971